ASXL1 and myeloid neoplasm: Mutations in ASXL1, a candidate tumor suppressor gene, are frequently observed in myeloid malignancies, such as acute myeloid leukemia and myelodysplastic syndrome (MDS), which are often associated with a poor prognosis [11,12,28,29,30].